TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07784608: An Open-label, Fixed-sequence, 3-period Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers

Sponsor: Huons Co., Ltd. · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 28 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,163,248

Rescue Site Savings

+$4,063,680

Unlock Full NCT07784608 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07784608 Rescue Dossier →